NumerixS Investment Technologies Inc - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 131 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2017$150,000
+2.7%
60,540
+46.6%
0.02%
+22.2%
Q4 2016$146,000–41,300–0.02%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders